Aardvark Therapeutics (AARD) Interest Income - Net (2024 - 2026)
Aardvark Therapeutics (AARD) reported Interest Income - Net of $889000.0 for Q1 2026, down 24.28% on a YoY basis from $1.2 million in Q1 2025, and down 20.98% sequentially from $1.1 million in Q4 2025.
Aardvark Therapeutics (AARD) Interest Income - Net (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Interest Income - Net data on file, last reported at $889000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Income - Net fell 24.28% year-over-year to $889000.0; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (up 1460.32% YoY), and the FY2025 full-year result was -$7.2 million, up 54.93% from the prior year.
- Interest Income - Net slipped to $889000.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Interest Income - Net ranged from a high of $1.5 million in Q2 2025 to a low of -$2.5 million in Q4 2024.
- A 3-year average of $583333.3 and a median of $1.0 million in 2024 frame the typical range for Interest Income - Net.
- Across the five-year window, Interest Income - Net surged 1039.81% in 2025 and dropped 24.28% in 2026, its largest moves.
- Tracing AARD's Interest Income - Net over 3 years: stood at -$2.5 million in 2024, then jumped by 145.77% to $1.1 million in 2025, then fell by 20.98% to $889000.0 in 2026.
- Business Quant data shows AARD's Interest Income - Net at $889000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -17.04 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - | 889,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 889,000.00 |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | -2.46 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 594,000.00 |
| Mar 31, 2024 | 103,000.00 |